Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2003
08/21/2003WO2002010392A9 Mammalian dna binding membrane-associated protein-encoding gene and uses
08/21/2003WO2002010358A3 Nucleotide incorporating enzymes
08/21/2003WO2002008453A3 Canine toxicity genes
08/21/2003WO2002006535A3 Method for breeding disease resistant domesticated fowl
08/21/2003WO2002004022A3 High fidelity polymerases and uses thereof
08/21/2003WO2001094641A3 Gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas
08/21/2003WO2001094630A3 Compositions and methods for array-based nucleic acid hybridization
08/21/2003WO2001092581A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
08/21/2003WO2001081929A3 Method and apparatus for predicting a signal peptide cleavage site
08/21/2003WO2001081916A3 Methods of evaluating transplant rejection
08/21/2003WO2001079479A3 Methods for selective targeting
08/21/2003WO2001077365A3 Antimicrobial methods and materials
08/21/2003WO2001059149A3 Peptide biosensors for anthrax protease
08/21/2003US20030159185 Replication protein A and use
08/21/2003US20030159162 Methods of using transporter-like molecules to treat pain and pain-related disorders
08/21/2003US20030159159 Human nerve growth factor exon 1 and exon 3 promoters
08/21/2003US20030159158 Method for identifying an agonist of neuronal calcium sensor-1 (NCS-1), for therapy of CNS disorders
08/21/2003US20030158602 Contacting a cell containing a NELL-1 gene with a test agent; and detecting a change in the expression level of Nell-1 gene as compared to the expression of the NELL-1 gene in a cell that is not contacted with test agent
08/21/2003US20030158499 Automated plunger-based sample/buffer mixing assembly
08/21/2003US20030158407 A Fluorescent dyes for labelling biopolymers and cell surface, a conjugated with polynucleotides or nucleotides
08/21/2003US20030158399 Compositions and methods for the treatment and diagnosis of immune disorders
08/21/2003US20030158398 Central nervous system disorders; psychological disorders
08/21/2003US20030158388 MAGE-10 encoding cDNA, the tumor rejection antigen precursor MAGE-10, antibodies specific to the molecule, and uses thereof
08/21/2003US20030158385 Novel fungal lipase
08/21/2003US20030158262 Ameliorating progression of amyotrophic lateral sclerosis
08/21/2003US20030158211 Methods and compositions for treatment of central nervous system disorders
08/21/2003US20030158187 Genetic polymorphisms in the preprotachy kinin gene
08/21/2003US20030158135 Derived from staphylococcal genes; use of the polynucleotides as oligonucleotide primers or probes for detecting Staphylococcal strains that are resistant to streptogramin A or streptogramin B and related compounds in biological sample
08/21/2003US20030158133 Use of such inhibitors or activators in treatment of dilated cardiomyopathy, pulmonary hypertension and/or other medical conditions related to PDE3 effects on cAMP levels in different intracellular compartments
08/21/2003US20030158109 As markers for distinguishing between tumors which will or have metastasized and those which are less likely to metastasize
08/21/2003US20030158105 Determining polypeptide sequence of at least one Bcr-Abl polypeptide expressed by the human cancer cell and comparing the polypeptide sequence of the Bcr-Abl polypeptide expressed by the human cancer cell to the Bcr-Abl polypeptide sequence
08/21/2003US20030158104 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030158099 Cancer therapy
08/21/2003US20030158085 For diagnosis and therapy of pancreatic disorders, particularly type I diabetes
08/21/2003US20030158083 For therapy of angiogenesis mediated disorders
08/21/2003US20030158081 Genetic polymorphisms in the human HMG-CoA reductase gene and their use in diagnosis and treatment of diseases
08/21/2003US20030157732 Capillary electrophoresis; gold complex; quantitative analysis
08/21/2003US20030157731 Analyte assay using particulate labels
08/21/2003US20030157723 Self-customizing analyte testing system for detection of drugs, ethanol and toxic substances in saliva; immunoassays
08/21/2003US20030157716 Recombinational cloning using nucleic acids having recombination sites
08/21/2003US20030157714 Apparatus for collecting detached cells, method of the same, and program for the same
08/21/2003US20030157713 Anchorage-dependent cell for propagating and measuring cytotoxic activity of lymphocyte; antitumor agents
08/21/2003US20030157705 Engineered recombinant molecule that regulates humoral and cellular effector functions of the immune system
08/21/2003US20030157704 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
08/21/2003US20030157696 Using rolling circle amplification (RCA) and transcription mediated amplification (TMA) to detect, diagnose and classify bacteria associated with food-borne illness
08/21/2003US20030157695 Marine actinomycete taxon for drug and fermentation product discovery
08/21/2003US20030157692 Papillomavirus infected epithelial cells and methods of producing infectious papillomavirus in epithelial cells and uses thereof
08/21/2003US20030157684 Microbial B-glucuronidase genes, gene production and uses thereof
08/21/2003US20030157682 Preparing preferential amino acid sequences in vitro; detecting restriction fragment length polymorphisms
08/21/2003US20030157660 Non-M, non-O HIV-1 strains, fragments and uses
08/21/2003US20030157651 Isolated GAGE-7B and 8 proteins
08/21/2003US20030157649 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/21/2003US20030157639 Comprises genetically engineered eotaxin mediated cytokine receptor (CCR3) with reduced internalized and/or kinase mediated phosphorylation; antiinflammatory agents
08/21/2003US20030157633 Comprises nucleotide sequences coding transmembrane protein/transport protein (TRPV3) for treating pain, inflammation and skin disorders
08/21/2003US20030157632 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157631 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157630 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157629 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157628 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157627 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157626 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157624 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157623 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157622 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157621 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157620 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157619 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157618 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157617 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157616 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157614 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157613 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157612 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157611 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157610 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157609 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157608 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157607 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157606 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157605 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157604 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157603 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157602 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157601 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157600 Comprises human cardiac sodium channel alpha polypeptide (SCN5A) for diagnosis and prevention arrhythmias; restriction fragment length polymorphisms; bradycardial agents
08/21/2003US20030157599 Comprises nucleotide sequence coding prostaglandin E receptor (EP3) for diagnosis and treatment of atherosclerotic diseases; restriction fragment length polymorphisms
08/21/2003US20030157598 Membrane protein associated with nuclear factor activated t-cells for diagnosing and treating cell proliferative/kidney disorders
08/21/2003US20030157597 Nucleotide sequences coding 103P2D6-related protein for diagnosing various tumors; anticarcinogenic agents; genetic vaccines
08/21/2003US20030157595 Fungal culture for generating neutral or alkaline glucanases for biopolishing, defribillating, bleaching, dyeing, or desizing textiles; laundry detergents
08/21/2003US20030157590 Detecting microorganism in dairy product by monitoring presence of microbial ATP present in milk following atpase digestion; fluorescence; bioassays
08/21/2003US20030157589 Detecting bactericides/enzyme inhibitor which prevent propagtion of bacterium associated with tuberculosis and leprosy; desaturases (DES); drug screening
08/21/2003US20030157588 Exposing source of active enzyme to sterilization cycle, contacting enzyme after cycle with aqueous buffer and substrate specific for and reactive with active enzyme to form enzyme modified product, detecting viable microorganisms
08/21/2003US20030157586 Device and method for conducting cellular assays using multiple fluid flow
08/21/2003US20030157585 Subjecting to in situ zymography a specimen isolated from a mammal that has received the compound exhibiting matrix metalloproteinase-inhibitory activity
08/21/2003US20030157584 Liquid for assaying alpha-amylase activity
08/21/2003US20030157583 Methods for determining squalene synthase activity
08/21/2003US20030157581 Use of an imaging photoelectric flat sensor for evaluating biochips and imaging method therefor
08/21/2003US20030157573 Use of Axl receptor for diagnosis and treatment of renal disease
08/21/2003US20030157572 Determining phosphorylation state of a serine corresponding the residue 1981 of Ataxia-Telangiectasia Mutated kinase protein in a cell; the phosphorylation state of serine is indicative of activation state of ATM kinase
08/21/2003US20030157564 Plunger-based flow immunoassay assembly
1 ... 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 ... 3003